Sign in →

Test ID: PCAB Parietal Cell Antibodies, IgG, Serum

Reporting Name

Parietal Cell Ab, IgG, S

Useful For

Evaluating patients suspected of having pernicious anemia or immune-mediated deficiency of vitamin B12 with or without megaloblastic anemia

Clinical Information

Pernicious anemia (PA) is characterized by atrophic body gastritis (ABG) and is the end state of a progressive disease known as autoimmune chronic atrophic gastritis.(1) In this disease, immune-mediated inflammation leads to destruction of gastric parietal cells with the resultant loss of intrinsic factor production and the inability to absorb dietary vitamin B12. Diagnosis of PA involves demonstrating the presence of a macrocytic anemia in the context of vitamin B12 deficiency, as well as documenting positive autoantibody serology, specifically anti-parietal cell antibody (PCA) and intrinsic factor antibody (IFA).(2) PCAs bind to the alpha- and beta-subunits of the membrane-bound H(+)/K(+)-ATPase. In contrast, IFAs bind directly to intrinsic factor, blocking its ability to bind vitamin B12.(1,2) Both PCAs and IFAs are useful diagnostic markers for PA. In a recently published study, PCAs were 81% sensitive and 90% specific for ABG, while IFAs were 27% sensitive and 100% specific. The study concluded that a combination of PCA and IFA testing was the optimal strategy for the evaluation of patients with suspected PA.(4)


A positive result indicates the presence of IgG antibodies to H(+)/K(+) ATPase and suggests the possibility of pernicious anemia (PA) or a related autoimmune disease.


A negative result indicates no detectable IgG antibodies to H(+)/K(+) ATPase; it does not rule out PA.


An equivocal result is indeterminate.

Analytic Time

1 day

Day(s) and Time(s) Performed

Tuesday, Friday; 3 p.m.

Clinical Reference

1. Toh BH, Van Driel IR, Gleeson PA: Pernicious anemia. N Eng J Med 1997;337(20):1441-1448

2. Lahner E, Annibale B: Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 2009;15(41):5121-5128

3. Lahner E, Normal GL, Severi C, et al: Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009;104(8):2071-2079

4. Product Insert: QUANTA Lite GPA, INOVA Diagnostics, Inc., San Diego, CA

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Specimen Type


Specimen Required


Preferred: Serum gel

Acceptable: Red top

Specimen Volume: 0.5 mL

Specimen Minimum Volume

0.45 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 21 days
  Frozen  21 days

Reference Values

Negative: ≤20.0 Units

Equivocal: 20.1-24.9 Units

Positive: ≥25.0 Units 

Reference values apply to all ages.

Test Classification

This test has been cleared, approved or is exempt by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information


LOINC Code Information

Test ID Test Order Name Order LOINC Value
PCAB Parietal Cell Ab, IgG, S 40960-7


Result ID Test Result Name Result LOINC Value
PCAB Parietal Cell Ab, IgG, S 40960-7
Mayo Clinic Laboratories | Neurology Catalog Additional Information:

mml-Behavioral, mml-Movement-Disorders, mml-Neuroimmunology, mml-Spinal-Cord, mml-Neuro-ophthalmology